These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 7322949)

  • 1. Craviten hydrolysis in plasma in vitro.
    Pogonowska-Wala E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):365-71. PubMed ID: 7322949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic investigations of Craviten. II. Dose-dependent elimination kinetics in rats following rapid intravenous injection.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):933-9. PubMed ID: 7243690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic investigations of Craviten. IV. First-pass metabolism in rats.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):949-53. PubMed ID: 7243692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic hydrolysis of pentaerythritoltetranicotinate and meso-inositolhexanicotinate in blood and tissues.
    Harthon L; Brattsand R
    Arzneimittelforschung; 1979; 29(12):1859-62. PubMed ID: 546424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma.
    Welch RM; Brown A; Ravitch J; Dahl R
    Clin Pharmacol Ther; 1995 Aug; 58(2):132-42. PubMed ID: 7648763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic investigations of Craviten. I. Spectrofluorometric determination of the drug in biological material.
    Witek J; Danek A
    Pol J Pharmacol Pharm; 1980; 32(6):927-32. PubMed ID: 7243689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic investigations of Craviten. III. Tissue distribution and elimination in rats.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):941-8. PubMed ID: 7243691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan-tethered opioid depots: synthetic strategies and release kinetics in vitro and in vivo.
    Gianolio DA; Philbrook M; Avila LZ; Young LE; Plate L; Santos MR; Bernasconi R; Liu H; Ahn S; Sun W; Jarrett PK; Miller RJ
    Bioconjug Chem; 2008 Sep; 19(9):1767-74. PubMed ID: 18717537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of anti-arrhythmia agent, gallanilide, on hepatic drug metabolizing enzymes in rats].
    Li D; Xu H; Yang J; Huang Y; Zhu H
    Yao Xue Xue Bao; 1984 Apr; 19(4):300-2. PubMed ID: 6496106
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of the metabolism and pharmacokinetics of sebacoyl dinalbuphine.
    Pao LH; Hsiong CH; Hu OY; Wang JJ; Ho ST
    Drug Metab Dispos; 2005 Mar; 33(3):395-402. PubMed ID: 15608131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of rat liver microsomal glutathione S-transferase by gallic acid.
    Shinno E; Shimoji M; Imaizumi N; Kinoshita S; Sunakawa H; Aniya Y
    Life Sci; 2005 Nov; 78(1):99-106. PubMed ID: 16125204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible and irreversible interactions of a cisplatin analog bearing a 1,2-diphenylethylenediamine ligand with plasma and plasma proteins in vitro.
    Bednarski PJ; Kratochwil NA; Otto AM
    Drug Metab Dispos; 1994; 22(3):419-27. PubMed ID: 7520852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: a comparison with the in vitro effects of butoxyacetic acid on rat and human erythrocytes.
    Udden MM
    J Appl Toxicol; 2000; 20(5):381-7. PubMed ID: 11139168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of flestolol esterase.
    Quon CY; Stampfli HF
    Res Commun Chem Pathol Pharmacol; 1993 Sep; 81(3):309-22. PubMed ID: 8235065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats.
    Priscilla DH; Prince PS
    Chem Biol Interact; 2009 May; 179(2-3):118-24. PubMed ID: 19146839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of vasoconstrictor response and inhibition of endothelium-dependent vasorelaxation by gallic acid in rat aorta.
    Sanae F; Miyaichi Y; Hayashi H
    Planta Med; 2002 Aug; 68(8):690-3. PubMed ID: 12221589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallic acid, a metabolite of the antioxidant propyl gallate, inhibits gap junctional intercellular communication via phosphorylation of connexin 43 and extracellular-signal-regulated kinase1/2 in rat liver epithelial cells.
    Kim JH; Kang NJ; Lee BK; Lee KW; Lee HJ
    Mutat Res; 2008 Feb; 638(1-2):175-83. PubMed ID: 18054051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro hydrolysis of steroid acid ester derivatives of prednisolone in plasma of different species.
    al-Habet SM; Lee HJ
    J Pharm Sci; 1990 Oct; 79(10):916-8. PubMed ID: 2280362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats.
    Stanely Mainzen Prince P; Priscilla H; Devika PT
    Eur J Pharmacol; 2009 Aug; 615(1-3):139-43. PubMed ID: 19450577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrolysis of vinyl acetate in human blood.
    Fedtke N; Wiegand HJ
    Arch Toxicol; 1990; 64(5):428-9. PubMed ID: 2403294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.